Insider Shareholders with Direct Ownership of Alexion Pharmaceuticals, Inc. (ALXN)
This section provides a comprehensive overview of the insiders with direct ownership of Alexion Pharmaceuticals, Inc. (ALXN). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
ALEXION PHARMACEUTICALS, INC. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Ludwig Hantson
CEO |
487,173 | 668,733 | 9,098 $1.66 Million | 6 |
Jul 21, 2021
Reduced 98.46%
|
|
Francois Nader
Director |
2,635 | 13,921 | 0 $0 | 2 |
Jul 21, 2021
Reduced 100.0%
|
|
Judith A Reinsdorf
Director |
2,635 | 14,150 | 0 $0 | 2 |
Jul 21, 2021
Reduced 100.0%
|
|
Christopher J Coughlin
Director |
2,691 | 42,347 | 0 $0 | 2 |
Jul 21, 2021
Reduced 100.0%
|
|
Brian Goff
EVP & Chief Commercial Officer |
125,294 | 173,313 | 0 $0 | 6 |
Jul 21, 2021
Reduced 100.0%
|
|
Deborah Dunsire
Director |
2,495 | 14,629 | 0 $0 | 2 |
Jul 21, 2021
Reduced 100.0%
|
|
Indrani Lall Franchini
EVP, Chief Compliance Officer |
108,623 | 136,841 | 0 $0 | 6 |
Jul 21, 2021
Reduced 100.0%
|
|
David R Brennan
Director |
3,336 | 20,873 | 0 $0 | 2 |
Jul 21, 2021
Reduced 100.0%
|
|
Tanisha Carino
EVP & CCAO |
43,846 | 62,143 | 0 $0 | 6 |
Jul 21, 2021
Reduced 100.0%
|
|
Paul A Friedman
Director |
2,495 | 12,840 | 0 $0 | 2 |
Jul 21, 2021
Reduced 100.0%
|
|
Aradhana Sarin
EVP, CFO |
96,157 | 130,914 | 0 $0 | 6 |
Jul 21, 2021
Reduced 100.0%
|
|
Daniel Bazarko
SVP, Controller, CAO |
68,761 | 93,085 | 0 $0 | 7 |
Jul 21, 2021
Reduced 100.0%
|
|
John J Orloff
EVP, Research & Development |
125,334 | 169,863 | 0 $0 | 7 |
Jul 21, 2021
Reduced 100.0%
|
|
Ellen Chiniara
EVP & Chief Legal Officer |
111,811 | 136,763 | 0 $0 | 6 |
Jul 21, 2021
Reduced 100.0%
|
|
Andreas Rummelt
Director |
2,495 | 28,109 | 0 $0 | 2 |
Jul 21, 2021
Reduced 100.0%
|
|
John T Mollen
Director |
2,635 | 15,336 | 0 $0 | 2 |
Jul 21, 2021
Reduced 100.0%
|